Remove 2023 Remove Compliance Remove COVID-19 Remove Health Services Administration
article thumbnail

DEA & SAMHSA Issue Temporary Rule Extending COVID-19 Telemedicine Flexibilities for Controlled Substances Prescribing Beyond the Termination of COVID-19 PHE

Hall Render

Notably, the Temporary Rule, which can be accessed here , extends the COVID-19 PHE telemedicine flexibilities (hereinafter, “telemedicine flexibilities”) for six months following the end of the PHE (through November 11, 2023).

article thumbnail

HIPAA Updates and HIPAA Changes in 2023

HIPAA Journal

Updates to HIPAA are long overdue but steps were finally made to update HIPAA in December 2020, when the HHS issued a notice of Proposed Rulemaking that detailed several proposed changes to the HIPAA Privacy Rule, and a Final Rule is now due which will likely see those HIPAA changes implemented in 2023. HIPAA Changes in 2023.

HIPAA 107
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

President Biden Signs End-of-Year Legislation Including Telehealth, Medicare & Medicaid, Mental Health, Pandemic Preparedness, and Other Health Care Provisions

C&M Health Law

On December 29, President Joe Biden signed into law the Consolidated Appropriations Act, 2023 ( P.L. We expect issues regarding regulation of diagnostic tests and mental health parity enforcement to resurface in the new Congress. 117-164 ) (the “Act”)—an approximately $1.7 117-164 ) (the “Act”)—an approximately $1.7

Medicaid 104
article thumbnail

Expanded Medicare Telehealth Coverage for Opioid Use Disorder Treatment Services Furnished by Opioid Treatment Programs

Healthcare Law Today

Starting January 1, 2023, Medicare will cover telehealth-based treatment services delivered by federally-accredited opioid treatment programs (OTPs), commonly referred to as “methadone clinics.” This flexibility will be in place until the end of CY 2023. Want to Learn More?

article thumbnail

The Wait is Over. Or Is It? DEA’s Proposed Rules Around Telemedicine Prescribing: Initial Impressions and Key Takeaways

Health Law Advisor

Both the proposed rules related to telemedicine prescribing of Schedule III-V non-narcotic controlled substances, and the separate proposed rules related to telemedicine prescribing of buprenorphine, were published in the Federal Register on March 1, 2023. This deadline came and went, also without meaningful action taken by DEA.

article thumbnail

Bonus Features – May 14, 2023 – Only 16% of organizations are using data to define clinical best practices, 84% of orgs hit with ransomware attacks lose revenue, and more

Healthcare IT Today

News In a temporary rule, the Drug Enforcement Administration (DEA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) extended telemedicine flexibilities for prescribing controlled medications for six months following the end of the public health emergency, through November 11.